Lupus Science & Medicine

Papers
(The H4-Index of Lupus Science & Medicine is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease184
Differences in reproductive health discussions in an urban Hispanic population with SLE: lessons from the field51
Evaluation and randomised controlled trial of home urinalysis testing in patients with SLE at elevated risk for developing lupus nephritis: a study protocol41
B lymphocytes in treatment-naive paediatric patients with lupus are epigenetically distinct from healthy children40
Genetic load in incomplete lupus erythematosus40
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort39
Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms33
Autoantibody-based subgroups and longitudinal seroconversion in juvenile-onset systemic lupus erythematosus33
Novel multiclass classification machine learning approach for the early-stage classification of systemic autoimmune rheumatic diseases31
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE30
Absence of renal remission portends poor long-term kidney outcome in lupus nephritis30
High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus28
Langerhans cells infiltration in lymph nodes of patients with systemic lupus erythematosus27
Canadian workplace experiences of systemic lupus erythematosus (SLE)25
Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE wit25
VPS13C and STING expression in neuropsychiatric systemic lupus erythematosus: unveiling an unbreached territory24
Quick Systemic Lupus Activity Questionnaire (Q-SLAQ): a simplified version of SLAQ for patient-reported disease activity23
Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials22
Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic response21
Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus Cohort20
Add-on sirolimus for the treatment of mild or moderate systemic lupus erythematosus via T lymphocyte subsets balance20
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine20
A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort20
0.068963050842285